CPAP In-home Assessment USA

Completed · Not applicable

Conditions studied: Obstructive Sleep Apnea

In brief

The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.

Key facts

Study ID

NCT02809859

Run by

Fisher and Paykel Healthcare

People needed

139

Starts

2016-07-01

Expected to finish

2017-04-01

Last updated by the study team

2019-03-05

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 22 and over
• Diagnosed with Obstructive Sleep Apnea (OSA) and prescribed Positive Airway Pressure (either Continuous positive airway pressure (CPAP) or AutoCPAP)
• For experienced users of PAP (CPAP or AutoCPAP) - you must be using PAP of more than 4 hours/night for 70% during the last 30 days.

You may not qualify if…

• Contraindicated for PAP (CPAP or AutoCPAP) therapy
• Has other significant sleep disorders (e.g periodic leg movements, insomnia, central sleep apnea)
• Has obesity hypoventilation syndrome or congestive heart failure
• Requires supplemental oxygen with their PAP (CPAP or AutoCPAP) device
• Has implanted electronic medical devices (e.g cardiac pacemakers)
• Pregnant or think they may be pregnant
• Not fluent in spoken and written English.

Where it is running

• Alabama Sleep Clinic — Huntsville, Alabama, United States
• Pulmonary Disease Specialists - Central Florida Sleep Centre — Kissimmee, Florida, United States
• Clayton Sleep Institute — St Louis, Missouri, United States
• Ohio Sleep Medicine and Neurosciences Institute — Dublin, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.